TherapeuticsMD Inc

NASDAQ: TXMD    
Share price (5/1/24): $1.89    
Market cap (5/1/24): $21.7 million
4 TherapeuticsMD Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Underwriting Agreements Filter

EX-1.2
from S-3ASR 44 pages Therapeuticsmd, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-1.1
from 8-K 37 pages Therapeuticsmd, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages Therapeuticsmd, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-1.1
from 8-K 39 pages Therapeuticsmd, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 38 pages Therapeuticsmd, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages Therapeuticsmd, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 34 pages Therapeuticsmd, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 36 pages Therapeuticsmd, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 31 pages Therapeuticsmd, Inc. $30,000,001.20 Common Stock Underwriting Agreement
12/34/56
EX-1
from 10-K 7 pages First Amendment to Lease
12/34/56
EX-1.1
from 8-K 31 pages Therapeuticsmd, Inc. $54,999,996.30 Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 33 pages Therapeuticsmd, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 49 pages 9,000,000 Shares Therapeuticsmd, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages 13,750,000 Shares Therapeuticsmd, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages 29,411,765 Shares Therapeuticsmd, Inc. Underwriting Agreement
12/34/56
EX-1
from 8-K 1 page Resignation
12/34/56
EX-1
from DEF 14A 1 page Underwriting agreement
12/34/56
EX-1
from 8-K/A 1 page Causey Demgen & Moore Inc. Certified Public Accountants and Consultants
12/34/56
EX-1
from 8-K 1 page Causey Demgen & Moore Inc. Certified Public Accountants and Consultants
12/34/56
EX-1
from SC TO-T/A 1 page News Release Jensen Development Reports Results of Tender Offer for Croff Class B Preferred Shares
12/34/56